Investment

Family offices and the life science nexus…and why it’s going to get much bigger

In a recent survey, Family Capital found 82% of family offices made life sciences a top choice when it came to venture capital investing. 

Subscribe

You will need a Premium+ Subscription to read this article.

Exclusive news, analysis and research on global family enterprise and private investment offices

SUBSCRIBE TODAY

Already have an account? Sign in

You need a Premium subscription.

To read Premium articles please subscribe.

SUBSCRIBE TODAY

Already have an account? Sign in

You've reached the end.

Continue reading free articles by registering as a Member.
Or choose a Premium Plan.

SUBSCRIBE TODAY

Already have an account? Sign in

Artal Group
  • Sector: Family Office
  • Country: LU
More Details
Fynveur
  • Sector: Principal Investment Office
  • Country: LU
More Details
Invus
Invus
  • Sector: Principal Investment Fund
  • Country: US
More Details

What to read next

Investment

Billionaires and their family offices, led by Steve Pagliuca and Michael Dell, want to boost the tech-driven revolution in life sciences by putting drug research and corporate funding under one roof
Investment

Despite its recent crash, family offices and other limited partners backing VC tech are keen to invest in deals in Europe in 2024, according to an annual survey by Atomico
Investment

“It AIn’t over till it’s over”, as baseball legend Yogi Berra nearly said, as family offices and other investors continue to commit record sums to AI. But

Leave a Reply